Ion Channels and Transporters

Membrane Transport Basics - Gateway Guardians

• Passive Transport (No ATP): Movement down an electrochemical gradient.
  • Simple Diffusion: Small, nonpolar molecules (e.g., O₂, CO₂) pass directly through the membrane. Rate proportional to gradient & lipid solubility.
  • Facilitated Diffusion: Via membrane proteins (channels or carriers) for specific solutes (e.g., glucose via GLUT, ions). Saturable kinetics.
  • Osmosis: Water movement across a semipermeable membrane from low to high solute concentration (or high to low water potential).
• Active Transport (Requires ATP): Movement against an electrochemical gradient.
  • Primary: Direct ATP hydrolysis fuels transport (e.g., Na⁺/K⁺-ATPase, H⁺ pumps).
  • Secondary: Uses energy from an ion gradient (established by primary active transport) to co-transport another solute (e.g., SGLT1 for glucose/Na⁺).
• Driving Forces: Governed by concentration and electrochemical gradients. For ions, transport energy is $\Delta G = RT \ln(C_2/C_1) + zF\Delta\Psi$. 📌 Mnemonic: Active PUMPS (uphill, ATP), Passive FLOWS (downhill, no ATP).

⭐ GLUT4 (glucose transporter) in muscle and adipose tissue is insulin-dependent, a key example of facilitated diffusion.

oka

Ion Channels - Selective Speedsters

Integral membrane proteins forming pores for rapid, selective ion passage. Governed by selectivity (ion-specific) and gating (open/closed states). Nernst potential: $E_{ion} = (RT/zF) \ln([ion]{out}/[ion]{in})$.

• Types & Examples:
  • Voltage-gated: Respond to membrane potential (Vm) changes.
    • Na+ channels (action potentials), K+ channels (repolarization), Ca2+ channels (neurotransmitter release).
  • Ligand-gated (Ionotropic): Ligand binding opens channel.
    • Nicotinic Acetylcholine Receptor (nAChR): Na+/K+ influx.
    • GABA-A Receptor: Cl- influx.
  • Mechanosensitive: Mechanical stress opens channel.

• Voltage-gated Na+ Channel States:

• Channelopathies (Diseases):
  • Cystic Fibrosis: Defective CFTR (functions as a Cl- channel).
  • Long QT Syndromes: Mutations in K+ or Na+ channel genes.

⭐ Tetrodotoxin (TTX) from pufferfish specifically blocks voltage-gated Na+ channels, halting action potentials.

📌 Remember: Lidocaine & Tetrodotoxin (TTX) are prominent blockers of voltage-gated Na+ channels.

Carrier Proteins - Picky Packers

Integral membrane proteins that bind specific solutes and undergo conformational changes to transport them across the membrane. Slower than ion channels.

• Properties:
  • Specificity: Bind to a specific molecule or a group of structurally similar molecules.
  • Saturation: Exhibit $V_{max}$ due to a finite number of binding sites, similar to enzyme kinetics.
  • Conformational Change: Essential for shuttling solutes.
• Kinetics: Follow Michaelis-Menten like kinetics ($K_m$ reflects affinity, $V_{max}$ is maximum transport rate).

Types of Carrier Proteins:

Active Transport Pumps - Energy Guzzlers

• Active Transport: Solute movement against gradient; needs energy.
• Primary Active Transport: Direct ATP hydrolysis.
  • P-type ATPases: Phosphorylated.
    • Na+/K+ ATPase: Pumps $\textbf{3 Na}^+ \textbf{ out}$ & $\textbf{2 K}^+ \textbf{ in}$. 📌 PUMPKIN. Inhibitor: Ouabain.
    • Ca2+ ATPase (SERCA): Pumps Ca2+ into SR/ER.
    • H+/K+ ATPase: Gastric H+ secretion. Inhibitor: Omeprazole.
  • F-type ATPases: ATP Synthase (mitochondria).
  • V-type ATPases: Acidify lysosomes, endosomes.
  • ABC Transporters (ATP-Binding Cassette):
    • CFTR: Cl- channel.
    • MDR1/P-glycoprotein: Drug efflux.
• Secondary Active Transport: Uses gradient from primary transport. E.g., SGLT1 (Na+-glucose cotransporter).

Table: Key Active Transporters

Start["🔋 Step 1: Binding
• ATPase + 3 Na+ in• Cytosolic binding"]

Phos["⚡ Phosphorylation
• ATP hydrolysis• Structural change"]

NaOut["📤 Na+ Efflux
• 3 Na+ out• Extracellular exit"]

Dephos["🔄 Dephosphorylation
• Pi release• Return to E1 state"]

KIn["📥 K+ Influx
• 2 K+ in• Intracellular move"]

Start -->|Using ATP| Phos Phos --> NaOut NaOut -->|2 K+ binds| Dephos Dephos --> KIn KIn --> Start

style Start fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style Phos fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C style NaOut fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252 style Dephos fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style KIn fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252

![Na+/K+ ATPase pump mechanism](https://ylbwdadhbcjolwylidja.supabase.co/storage/v1/object/public/notes/L1/Biochemistry_Membrane_Biochemistry_Ion_Channels_and_Transporters/e9a5ada8-5069-4549-8b35-1a5ea3acfed3.gif)

> ⭐ **Mutations in the CFTR gene, an ABC transporter, cause Cystic Fibrosis by disrupting chloride ion transport.**

##  High‑Yield Points - ⚡ Biggest Takeaways
> * **Ion channels** mediate **rapid, passive diffusion** of ions down **electrochemical gradients**.
> * **Voltage-gated channels** (e.g., Na+, K+, Ca2+) respond to **membrane potential changes**.
> * **Ligand-gated channels** (e.g., nAChR, GABA-A) are activated by **neurotransmitter binding**.
> * **Transporters** (carriers/permeases) facilitate **slower, conformational change-dependent** solute movement.
> * **Primary active transport** uses **ATP hydrolysis** to move solutes **against concentration gradients** (e.g., Na+/K+ ATPase).
> * **Secondary active transport** couples solute movement to an **existing ion gradient** (e.g., SGLT1).
> * **Channelopathies** (e.g., Cystic Fibrosis - CFTR, Long QT syndrome - KCNQ1) are diseases due to **defective ion channels** or transporters.